Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8671399 | Journal of Vascular Surgery | 2018 | 11 Pages |
Abstract
Results of this “real-world” experience suggest that the use of F/B-EVAR for the treatment of cAAAs in high-risk surgical patients is safe and effective and has comparable short-term results to those of low-risk patients undergoing OR. Patients treated by F/B-EVAR had shorter ICU and hospital LOS, lower MAEs, and faster convalescence. A decrease in procedure time and radiation dose was noted as experience was gained, even as complexity increased.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jesse MD, Timothy MD, Ross MS, MBA, Peter MD, Jason MD, Nedaa MD, Jessica MD, Elliott MD, Andrew MD,